DSG3 and pemphigus: A deeper analysis of the active pemphigus mouse model revealed that, in these mice, a single Dsg3-specific CD4+ T-cell clone was able to induce a clinical phenotype in recipient mice by activating Dsg3-reactive B cells (Takahashi et al., 2008).